The US Food and Drug Administration (FDA) has authorized a libido-enhancing drug for women that has been dubbed “Female Viagra”.
Flibanserin, a drug constructed by Sprout Pharmaceuticals, recently upheld an FDA advisory cabinet meeting.
The tablet is designed to support premenopausal women recover their sex expostulate by boosting levels of certain mind chemicals, though critics contend it has singular effects.
Elaine Jung reports.
